IMC Chicago’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.4M | Sell |
659,500
-370,800
| -36% | -$28.6M | 0.02% | 519 |
|
|
2025
Q4 | $81.8M | Buy |
1,030,300
+45,000
| +5% | +$3.55M | 0.03% | 345 |
|
|
2025
Q3 | $74.3M | Buy |
985,300
+116,000
| +13% | +$7.95M | 0.03% | 358 |
|
|
2025
Q2 | $60M | Sell |
869,300
-53,900
| -6% | -$3.53M | 0.03% | 335 |
|
|
2025
Q1 | $62.5M | Sell |
923,200
-136,100
| -13% | -$8.14M | 0.04% | 262 |
|
|
2024
Q4 | $47.6M | Buy |
1,059,300
+385,000
| +57% | +$21.6M | 0.02% | 357 |
|
|
2024
Q3 | $42.4M | Sell |
674,300
-43,000
| -6% | -$2.51M | 0.02% | 342 |
|
|
2024
Q2 | $42.4M | Buy |
717,300
+355,600
| +98% | +$22.2M | 0.03% | 332 |
|
|
2024
Q1 | $28.8M | Buy |
361,700
+21,500
| +6% | +$1.64M | 0.02% | 370 |
|
|
2023
Q4 | $26.9M | Sell |
340,200
-30,100
| -8% | -$2.14M | 0.02% | 385 |
|
|
2023
Q3 | $25.9M | Sell |
370,300
-38,800
| -9% | -$2.75M | 0.02% | 316 |
|
|
2023
Q2 | $28.3M | Buy |
409,100
+28,600
| +8% | +$2.03M | 0.03% | 296 |
|
|
2023
Q1 | $28.3M | Buy |
380,500
+155,900
| +69% | +$13.1M | 0.03% | 260 |
|
|
2022
Q4 | $20.9M | Buy |
224,600
+38,700
| +21% | +$3.73M | 0.03% | 296 |
|
|
2022
Q3 | $17.7M | Sell |
185,900
-59,700
| -24% | -$5.91M | 0.02% | 317 |
|
|
2022
Q2 | $22.8M | Sell |
245,600
-29,900
| -11% | -$2.92M | 0.03% | 269 |
|
|
2022
Q1 | $27.9M | Sell |
275,500
-122,300
| -31% | -$12.8M | 0.03% | 280 |
|
|
2021
Q4 | $41M | Buy |
397,800
+66,900
| +20% | +$6.18M | 0.03% | 237 |
|
|
2021
Q3 | $28.1M | Buy |
330,900
+86,000
| +35% | +$7.2M | 0.03% | 287 |
|
|
2021
Q2 | $20.4M | Sell |
244,900
-9,000
| -4% | -$737K | 0.03% | 324 |
|
|
2021
Q1 | $19.1M | Sell |
253,900
-8,100
| -3% | -$590K | 0.03% | 304 |
|
|
2020
Q4 | $17.9M | Buy |
262,000
+140,400
| +115% | +$9.13M | 0.02% | 292 |
|
|
2020
Q3 | $7.1M | Buy |
121,600
+11,700
| +11% | +$728K | 0.01% | 364 |
|
|
2020
Q2 | $7.14M | Sell |
109,900
-53,200
| -33% | -$3.35M | 0.01% | 314 |
|
|
2020
Q1 | $9.68M | Buy |
163,100
+49,400
| +43% | +$3.3M | 0.02% | 218 |
|
|
2019
Q4 | $8.45M | Sell |
113,700
-24,600
| -18% | -$1.73M | 0.02% | 247 |
|
|
2019
Q3 | $8.72M | Buy |
138,300
+6,800
| +5% | +$403K | 0.03% | 197 |
|
|
2019
Q2 | $7.17M | Buy |
131,500
+55,300
| +73% | +$2.98M | 0.02% | 223 |
|
|
2019
Q1 | $4.11M | Buy |
76,200
+44,800
| +143% | +$2.77M | 0.01% | 264 |
|
|
2018
Q4 | $2.06M | Buy |
+31,400
| New | +$2.34M | 0.01% | 341 |
|
Other funds holding CVS
VCM
VPM
IMC Chicago's CVS Position: Q1 2026 in Review
IMC Chicago reduced its CVS Health (CVS) stake by 35% in Q1 2026, selling an estimated $3.62M and leaving 86,636 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1615.
IMC Chicago first reported a position in CVS in Q1 2020 and has held it in 6 quarters since. The position peaked at $10.6M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- IMC Chicago held 86,636 shares of CVS Health worth $6.22M as of Q1 2026.
- IMC Chicago sold 46,975 CVS Health shares in Q1 2026, an estimated $3.62M.
- CVS Health made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1615 holding.
- IMC Chicago first reported a position in CVS Health in Q1 2020 and has held it in 6 quarters since.
- IMC Chicago's CVS Health position peaked at $10.6M in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.